IPD
IMPEDIMED FPO [IPD]
Healthcare · ASX Small Cap
$0.0180 +5.9%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score -5First seen: 2026-02-25
Score Breakdown
Technical69
Catalyst51
Sentiment50
Fundamental87
Momentum42
Risk Gate20
Active Signals
Bullish Signals
- RSI approaching oversold
- MACD momentum strengthening
- Bollinger squeeze (breakout building)
- OBV divergence: distribution detected
- Strong 5-day momentum (+12.5%)
- Volatility contracting (breakout setup)
- Adequate cash runway (6 quarters)
- Low P/S ratio (2.7x)
- Strong revenue growth (+21%)
- EPS estimates revised upward (+10pts)
- Near 52-week low (5% of range)
- Small-cap ($20-100M)
- CANSLIM I: Institutional ownership (15%)
- Altman Z-Score in distress zone (1.08 < 1.81)
- Penny stock risk ($0.017)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
- Trial readout: (est. 2007-12)
Risk Signals
- Below 200-day MA (long-term downtrend)
- Deeply negative margins (-183%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
- Negative 12-1 momentum (-43%)
Recent Catalysts
NONE FY26 Half Year Financial Results
NONE Appendix 4D and Interim Financial Report
NONE Initial Director's Interest Notice - Mr Erik Anderson
Recent ASX Announcements
| 2026-02-25 | FY26 Half Year Financial Results PRICE SENSITIVE |
| 2026-02-25 | Appendix 4D and Interim Financial Report PRICE SENSITIVE |
| 2026-02-25 | Initial Director's Interest Notice - Mr Erik Anderson |
| 2026-02-25 | Appointment of Independent Non-executive Director |
| 2026-02-09 | Change of Director's Interest Notice - Ms Emmanuel-Donnelly |
Key Metrics
$34.7M
Market Cap
9.4M
Avg Volume
1.9x
Vol Ratio
$0.01 — $0.06
52-Week Range
0.5%
Short Interest
N/A
Cash Runway
-75.9%
ROE
-182.6%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 88% |
| L | Leader vs Laggard | laggard | RS: -10 |
| I | Institutional Sponsorship | pass | Inst: 15% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #52 of 119 · Sector avg: 51
View all Healthcare signals →